Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1978 Aug;63(4):671–675. doi: 10.1111/j.1476-5381.1978.tb17281.x

The effects of alpha-adrenoceptor antagonists on contractile responses to 5-hydroxytryptamine in dog saphenous vein.

P P Humphrey
PMCID: PMC1668113  PMID: 28807

Abstract

1 5-Hydroxytryptamine (5-HT) contracted isolated saphenous vein strips of the dog, producing a biphasic concentration-effect curve. The first phase occurred with low concentrations of 5-HT (1.0 X 10(-8) TO 5.0 X 10(-6) mol/l) with a plateau between 1.0 x 10(-6) mol/l and 1.0 x 10(-5) mol/l. The second phase occurred with high concentrations of 5-HT (greater than 1.0 x 10(-5) mol/l). 2 The alpha-adrenoceptor antabonists, phentolamine (5.0 x 10(-8) to 5.0 x 10(-7) mol/l), labetalol (1.0 x 10(-6) to 1.0 x 10(-5) mol/l) and thymoxamine (1.0 x 10(-6) to 1.0 x 10(-5) mol/l), antagonized responses to high concentrations of 5-HT but responses to low concentrations of 5-HT were not antagonized. 3 The effects of high concentrations of 5-HT were antagonized by cocaine (1.0 x 10(-6) to 1.0 x 10(-5) mol/l) and were not evident in veins removed from dogs pretreated with syrosingopine. 5-HT receptors and that high concentrations of 5-HT also act indirectly on alpha-adrenoceptors by displacing noradrenaline from neuronal stores.

Full text

PDF
672

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Apperley E., Humphrey P. P., Levy G. P. Receptors for 5-hydroxytryptamine and noradrenaline in rabbit isolated ear artery and aorta. Br J Pharmacol. 1976 Oct;58(2):211–221. doi: 10.1111/j.1476-5381.1976.tb10398.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Apperley E., Humphrey P. P., Levy G. P. Two types of excitatory receptor for 5-hydroxytryptamine in dog vasculature? [proceedings]. Br J Pharmacol. 1977 Nov;61(3):465P–465P. [PMC free article] [PubMed] [Google Scholar]
  3. Brandão F. A comparative study of the role played by some inactivation pathways in the disposition of the transmitter in the rabbit aorta and the saphenous vein of the dog. Blood Vessels. 1976;13(5):309–318. doi: 10.1159/000158100. [DOI] [PubMed] [Google Scholar]
  4. Carrier O., Jr, Holland W. C. Supersensitivity in perfused isolated arteries after reserpine. J Pharmacol Exp Ther. 1965 Aug;149(2):212–218. [PubMed] [Google Scholar]
  5. Edvinsson L., Hardebo J. E. Characterization of serotonin-receptors in intracranial and extracranial vessels. Acta Physiol Scand. 1976 Aug;97(4):523–525. doi: 10.1111/j.1748-1716.1976.tb10293.x. [DOI] [PubMed] [Google Scholar]
  6. Feniuk W., Humphrey P. P., Levy G. P. Further evidence for two types of excitatory receptor for 5-hydroxytryptamine in dog vasculature [proceedings]. Br J Pharmacol. 1977 Nov;61(3):466P–466P. [PMC free article] [PubMed] [Google Scholar]
  7. Fozard J. R. Comparative effects of four migraine prophylactic drugs on an isolated extracranial artery. Eur J Pharmacol. 1976 Mar;36(1):127–139. doi: 10.1016/0014-2999(76)90264-8. [DOI] [PubMed] [Google Scholar]
  8. Fozard J. R., Mwaluko G. M. Mechanism of the indirect sympathomimetic effect of 5-hydroxytrypt-amine on the isolated heart of the rabbit. Br J Pharmacol. 1976 May;57(1):115–125. doi: 10.1111/j.1476-5381.1976.tb07661.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. GADDUM J. H. Theories of drug antagonism. Pharmacol Rev. 1957 Jun;9(2):211–218. [PubMed] [Google Scholar]
  10. GILLIS C. N. CHARACTERISTICS OF NOREPINEPHRINE RETENTION BY A SUBCELLULAR FRACTION OF RABBIT HEART. J Pharmacol Exp Ther. 1964 Oct;146:54–60. [PubMed] [Google Scholar]
  11. Haefely W. The effects of 5-hydroxytryptamine and some related compounds on the cat superior cervical ganglion in situ. Naunyn Schmiedebergs Arch Pharmacol. 1974;281(2):145–165. doi: 10.1007/BF00503495. [DOI] [PubMed] [Google Scholar]
  12. Humphrey P. P. The effects of uptake1 on alpha-adrenoceptor antagonist potency in dog saphenous vein. Br J Pharmacol. 1978 Aug;63(4):665–669. doi: 10.1111/j.1476-5381.1978.tb17280.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. INNES I. R. An action of 5-hydroxytryptamine on adrenaline receptors. Br J Pharmacol Chemother. 1962 Dec;19:427–441. doi: 10.1111/j.1476-5381.1962.tb01447.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Iversen L. L. The inhibition of noradrenaline uptake by drugs. Adv Drug Res. 1965;2:1–46. [PubMed] [Google Scholar]
  15. Jester J., Horst W. D. Influence of serotonin on adrenergic mechanisms. Biochem Pharmacol. 1972 Feb 1;21(3):333–338. doi: 10.1016/0006-2952(72)90344-9. [DOI] [PubMed] [Google Scholar]
  16. ORLANS F. B., FINGER K. F., BRODIE B. B. Pharmacological consequences of the selective release of peripheral norepinephrine by syrosingopine (Su 3118). J Pharmacol Exp Ther. 1960 Feb;128:131–139. [PubMed] [Google Scholar]
  17. Thoa N. B., Eccleston D., Axelrod J. The accumulation of C14-serotonin in the guinea-pig vas deferens. J Pharmacol Exp Ther. 1969 Sep;169(1):68–73. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES